XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Intel, Oracle and IBM Object to OKX–ICE Tokenized Stock Plans
Intel, Oracle, IBM and IonQ have formally objected to the OKX–ICE tokenized stock plans, according to an October 26 public notice published by OKXICE — the join...
Ark Invest Buys Circle Shares, Sells Bitcoin ETF as BTC Falls
The two moves point in opposite directions within the crypto-linked investment space. Ark added exposure to Circle, the USD Coin issuer and stablecoin infrastru...
Ripple Approved to Operate as a U.S. National Trust Bank
A national trust bank is a federally chartered institution authorized to provide trust and fiduciary services, including asset custody, without engaging in comm...
Ethereum Foundation’s Latest ETH Sale Draws Criticism
The Ethereum Foundation has drawn fresh criticism following its latest sale of ETH, with observers describing the timing and communication around the transactio...
Strategy Pauses Bitcoin Buys as STRC Buybacks Continue
Strategy’s latest weekly update showed no new Bitcoin purchase reported, while the company continued repurchasing shares of its STRC preferred stock. The diverg...
Bitcoin Tests $80K as $550M Crypto Liquidations Hit
Bitcoin is testing the $80,000 support level as reports of roughly $550 million in crypto liquidations circulate across market data platforms. Whether BTC can h...
